Investing Profile

James Healy

InvestorVC
Managing Partner at Sofinnova Investments
sofinnova.com/team/james-heal...Menlo Park, California
Photo of James Healy, Managing Partner at Sofinnova Investments

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Sofinnova Investments Managing Partner
$100K - $5.0M
$1.5M
35
CompanyStageDateRound SizeTotal Raised
Seaport Therapeutics
Series AApr 2024$100M
$330M
Co-investors: Brett Zbar (General Atlantic), Robert Nelsen (ARCH Venture Partners)
BioAge Labs
Series DFeb 2024$170M
$290M
Co-investors: Vijay Pande (VZVC), Ling Wong (Highbury Group), Elad Gil
Rapport Therapeutics
Series BAug 2023$150M
$250M
Co-investors: Sanjay Mistry (Johnson & Johnson Innovation), Steve Paul (Third Rock Ventures), Reid Huber (Third Rock Ventures)
ArriVent
Series BDec 2022$160M
$160M
Co-investors: Carl Gordon (OrbiMed)
CinCor Pharma
Series BOct 2021$140M
Series AMay 2019$50M
$190M
Co-investors: Maina Bhaman (Soffinova Partners), David Allison (Westlake Village BioPartners)
Karuna Therapeutics
Series BMar 2019$68M
$110M
Co-investors: Steve Paul (Third Rock Ventures), Robert Nelsen (ARCH Venture Partners), Heather Preston
ObsEva
Post Ipo EquityOct 2017$60M
Series BNov 2015$59M
Series AAug 2013$34M
$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA))
Iterum Therapeutics
Series AMar 2016$40M
$110M
Co-investors: Brent Ahrens (Canaan Partners), Patrick Heron (Frazier Healthcare Partners), Mark Chin (Arix Bioscience)